Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Buddhahead]

A New Treatment For Inflammatory Diseases Read more from Asian Scientist Magazine, February 27, 2015

Excerpts:
"The molecule MCC950 targets the inflammasomes and could be used to treat diseases such as cryopyrin-associated periodic syndromes. "

"Scientists have developed a small molecule that blocks a key driver of inflammatory diseases. Their results, published in Nature Medicine, could inspire new treatments for arthritis, multiple sclerosis and a family of rare autoinflammatory diseases. University of Queensland scientists worked with an international team, including experts from Trinity College Dublin, to study the molecule known as MCC950. The molecule can suppress activation of a key process in inflammation caused by inflammasomes, crucial drivers of many autoinflammatory diseases. "


Read more from Asian Scientist Magazine at: http://www.asianscientist.com/2015/02/in-the-lab/treatment-inflammatory-diseases/